Anna Planas-Ballvé1, Ane Miren Crespo1, Lorena Martín Aguilar1, María Hernández-Pérez1, Tamara Canento1, Laura Dorado1, María T Alzamora2, Pere Torán3, Guillem Pera3, Laura Muñoz-Ortiz4, Juan F Arenillas5, María Castañón6, Antoni Dávalos1, Mónica Millán1, Elena López-Cancio7. 1. Departamento de Neurociencias, Hospital Universitario Germans Trias I Pujol, Badalona, Barcelona, Spain. 2. Atención Primaria, ABS Nord-Riu Sud, Santa Coloma de Gramenet, Barcelona, Spain; Unitat de Suport a La Recerca (USR) Metropolitana Nord, IDIAP-J Gol, Mataró, Spain. 3. Unitat de Suport a La Recerca (USR) Metropolitana Nord, IDIAP-J Gol, Mataró, Spain. 4. Agència de Qualitat I Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain. 5. Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Spain. 6. Servicio de Neurología, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain. 7. Servicio de Neurología, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain. Electronic address: elenacancio@gmail.com.
Abstract
BACKGROUND AND AIMS: Symptomatic intracranial atherosclerosis (ICAS) is associated with a high risk of stroke recurrence and occurrence of other vascular events. However, ICAS has been poorly studied from its asymptomatic stage. The objective of our study was to determine if subclinical intracranial atherosclerosis is associated with long-term incident vascular events in Caucasians. METHODS: The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) Study is a population-based study that enrolled 933 subjects with a moderate-high vascular risk and without history of stroke or coronary disease, and determined the prevalence of asymptomatic ICAS and associated risk factors. At baseline visit, carotid atherosclerosis and ICAS were screened by color-coded duplex ultrasound, and moderate-severe stenosis was confirmed by magnetic resonance angiography. At baseline, 8.9% of subjects had asymptomatic ICAS, of whom 3.3% were moderate-severe. In the longitudinal phase, subjects were prospectively followed-up to assess the incidence of a combined primary endpoint of vascular events (stroke, acute coronary syndrome and/or vascular death). RESULTS: After 7.17 years of follow-up, there were 51 incident cerebrovascular events (16 transient ischemic attacks, 27 ischemic, 8 hemorrhagic strokes), 63 incident coronary events and 23 vascular deaths. After multivariate Cox regression analyses adjusted by age, sex, vascular risk and presence of carotid plaques, ICAS was an independent predictor for overall vascular events (HR 1.83 [1.10-3.03], p = 0.020), and moderate-severe intracranial stenosis was also an independent predictor for cerebrovascular events (HR 2.66 [1.02-6.94], p = 0.046). CONCLUSIONS: Asymptomatic ICAS is independently associated with the incidence of future vascular events in our population. These findings might have implications for the development of primary prevention strategies.
BACKGROUND AND AIMS: Symptomatic intracranial atherosclerosis (ICAS) is associated with a high risk of stroke recurrence and occurrence of other vascular events. However, ICAS has been poorly studied from its asymptomatic stage. The objective of our study was to determine if subclinical intracranial atherosclerosis is associated with long-term incident vascular events in Caucasians. METHODS: The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) Study is a population-based study that enrolled 933 subjects with a moderate-high vascular risk and without history of stroke or coronary disease, and determined the prevalence of asymptomatic ICAS and associated risk factors. At baseline visit, carotid atherosclerosis and ICAS were screened by color-coded duplex ultrasound, and moderate-severe stenosis was confirmed by magnetic resonance angiography. At baseline, 8.9% of subjects had asymptomatic ICAS, of whom 3.3% were moderate-severe. In the longitudinal phase, subjects were prospectively followed-up to assess the incidence of a combined primary endpoint of vascular events (stroke, acute coronary syndrome and/or vascular death). RESULTS: After 7.17 years of follow-up, there were 51 incident cerebrovascular events (16 transient ischemic attacks, 27 ischemic, 8 hemorrhagic strokes), 63 incident coronary events and 23 vascular deaths. After multivariate Cox regression analyses adjusted by age, sex, vascular risk and presence of carotid plaques, ICAS was an independent predictor for overall vascular events (HR 1.83 [1.10-3.03], p = 0.020), and moderate-severe intracranial stenosis was also an independent predictor for cerebrovascular events (HR 2.66 [1.02-6.94], p = 0.046). CONCLUSIONS: Asymptomatic ICAS is independently associated with the incidence of future vascular events in our population. These findings might have implications for the development of primary prevention strategies.
Authors: Marios Psychogios; Alex Brehm; Elena López-Cancio; Gian Marco De Marchis; Elena Meseguer; Aristeidis H Katsanos; Christine Kremer; Peter Sporns; Marialuisa Zedde; Adam Kobayashi; Jildaz Caroff; Daniel Bos; Sabrina Lémeret; Avtar Lal; Juan F Arenillas Journal: Eur Stroke J Date: 2022-06-03
Authors: Marina Petrova Krasteva; Kui Kai Lau; Pasquale Mordasini; Anderson Chun On Tsang; Mirjam Rachel Heldner Journal: Adv Ther Date: 2020-04-08 Impact factor: 3.845
Authors: Robert Hurford; Frank J Wolters; Linxin Li; Kui Kai Lau; Wilhelm Küker; Peter M Rothwell Journal: JAMA Neurol Date: 2020-08-01 Impact factor: 18.302
Authors: Qiao Wang; Yuanyuan Zhao; Xiang Wang; Xiaokang Ji; Shaowei Sang; Sai Shao; Xiaotong Ma; Guangbin Wang; Ming Lv; Fuzhong Xue; Yifeng Du; Qinjian Sun Journal: BMJ Open Diabetes Res Care Date: 2020-12
Authors: Jose Gutierrez; Farid Khasiyev; Minghua Liu; Janet T DeRosa; Sarah E Tom; Tatjana Rundek; Ken Cheung; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind Journal: J Am Coll Cardiol Date: 2021-08-10 Impact factor: 27.203